시너지이노베이션

048870KOSDAQ의료용 기기 제조업

56.5 / 100

Reference Date: 2026-04-13

Financial Score29.0 / 40

News Sentiment12.5 / 25

Momentum5.0 / 20

Disclosure10.0 / 15

AI Analysis: PBR is significantly undervalued vs. peers and PER is significantly undervalued vs. peers is also solid. Slightly down 3.6% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

Synergy Innovation primarily manufactures and sells microbial culture media, produced in ISO13485 and KGMP-certified clean environments. In 2025, the company achieved total sales of 11.31 trillion KRW, with the medical sector contributing the largest share at 66.6%, followed by biotechnology (18.8%) and health functional food (12.4%). It operates through seven affiliated companies across biotechnology, medical devices, and health food sectors.

Number of Employees

65people

Average Salary

49.8M KRW

Score Calculation Basis

Detailed Financial Score

PER

15.91Industry Average 26.526.5Point

Lower than industry avg (good)

PBR

0.65Industry Average 1.707.0Point

Half of industry avg (excellent)

ROE

4.39Industry Average 8.002.5Point

Below industry avg

Debt Ratio

6.02Industry Average 10.955.0Point

Lower than industry avg (good)

Trend 2023~20258.0 / 10 points

Revenue Growth Rate

2.5 / 3

Avg ▲16.8% (2-year basis)

Operating Profit Growth Rate

2.5 / 3

Avg ▲13.2% (2-year basis)

ROE Trend

3.0 / 4

Avg ROE 5.4% (improving, 3yr)

Detailed News Sentiment

2 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position1.0Point

Near 52w low (4%, downtrend)

Current 2,020Won52-week high 4,01552-week low 1,928

1-month return2.0Point

1m -3.58% (slight drop)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

6 totalPositive 0Neutral 6Negative 0

Neutral[기재정정]주요사항보고서(타법인주식및출자증권양도결정)2026-04-01
Neutral정기주주총회결과2026-03-27
Neutral전환사채(해외전환사채포함)발행후만기전사채취득2026-03-23
Neutral감사보고서제출2026-03-19
Neutral사업보고서 (2025.12)2026-03-19